14 research outputs found
Cortical laminar necrosis after subarachnoid hemorrhage
ΠΠΎΡΡΠΈΠΊΠ°Π»Π½Π°ΡΠ° Π»Π°ΠΌΠΈΠ½Π°ΡΠ½Π° Π½Π΅ΠΊΡΠΎΠ·Π° Π΅ ΡΡΠ΄ΠΊΠΎ Π½Π°Π±Π»ΡΠ΄Π°Π²Π°Π½Π° ΠΏΡΠΈ ΠΏΠ°ΡΠΈΠ΅Π½Ρ ΡΠ»Π΅Π΄ Π΅ΠΌΠ±ΠΎΠ»ΠΈΠ·ΠΈΡΠ°Π½Π΅ Π½Π° ΠΌΠΎΠ·ΡΡΠ½Π° Π°Π½Π΅Π²ΡΠΈΠ·ΠΌΠ°. Π‘ΡΠΎΠ±ΡΠ°Π²Π°ΠΌΠ΅ ΡΠ»ΡΡΠ°ΠΉ Π½Π° 51-Π³ΠΎΠ΄ΠΈΡΠ½Π° ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΊΠ°, ΠΊΠΎΡΡΠΎ ΡΠ»Π΅Π΄ Π΅ΠΌΠ±ΠΎΠ»ΠΈΠ·Π°ΡΠΈΡ Π½Π° ΠΌΠΎΠ·ΡΡΠ½Π°ΡΠ° Π°Π½Π΅Π²ΡΠΈΠ·ΠΌΠ° Π½Π° Π΄ΡΡΠ½Π°ΡΠ° ΡΡΠ΅Π΄Π½Π° ΠΌΠΎΠ·ΡΡΠ½Π° Π°ΡΡΠ΅ΡΠΈΡ ΠΎΡΡΠ°Π²Π° Π² ΠΊΠΎΠΌΠ°ΡΠΎΠ·Π½ΠΎ ΡΡΡΡΠΎΡΠ½ΠΈΠ΅.ΠΡ ΠΈΠ·Π²ΡΡΡΠ΅Π½ΠΈΡ ΡΠ΄ΡΠ΅Π½ΠΎ-ΠΌΠ°Π³Π½ΠΈΡΠ΅Π½ ΡΠ΅Π·ΠΎΠ½Π°Π½Ρ ΠΈΠΌΠ°ΡΠ΅ Π²ΠΈΡΠΎΠΊ ΠΈΠ½ΡΠ΅Π½Π·ΠΈΡΠ΅Ρ Π½Π° ΡΠΈΠ³Π½Π°Π»Π° Π² ΡΠ΅ΠΌΠΏΠΎΡΠ°Π»Π½ΠΈΡ Π»ΠΎΠ± Π½Π° ΠΌΠΎΠ·ΡΠΊΠ° Π½Π° T2- ΠΈΠ·ΠΎΠ±ΡΠ°ΠΆΠ΅Π½ΠΈΡΡΠ°, ΠΈ Π»ΠΈΠ½Π΅Π°ΡΠ΅Π½ Ρ
ΠΈΠΏΠ΅ΡΠΈΠ½ΡΠ΅Π½Π·ΠΈΡΠ΅Ρ ΠΏΠΎ ΠΏΡΠΎΡΠ΅ΠΆΠ΅Π½ΠΈΠ΅ Π½Π° ΠΌΠΎΠ·ΡΡΠ½ΠΈΡΠ΅ ΠΊΠΎΡΠ°ΡΠ° Π½Π° T1-ΠΈΠ·ΠΎΠ±ΡΠ°ΠΆΠ΅Π½ΠΈΡΡΠ° Ρ Π΄ΠΈΡΡΠ·Π½ΠΎ ΡΡΠΈΠ»Π²Π°Π½Π΅ Π½Π° ΠΌΠΎΠ·ΡΡΠ½Π°ΡΠ° ΠΊΠΎΡΠ°.Cortical laminar necrosis has rarely been observed in a patient after coil embolization. We report a 51-year-old female patient who became comatose after the embolization of an aneurysm in the right middle cerebral artery. There were high signal intensities in the temporal brain on T2-weighted MRI images and linear hyperintensities along the cerebral cortices on T1-weighted images with a diffuse gyriform enhancement
Examining The Effect Of The Online Radiological Consultation Platform StatDx
StatDx Π΅ ΠΎΠ½Π»Π°ΠΉΠ½ ΠΏΠ»Π°ΡΡΠΎΡΠΌΠ° Π·Π° Π±ΡΡΠ·Π° ΡΠΏΡΠ°Π²ΠΊΠ° Π² ΠΏΠΎΠ»Π·Π° Π½Π° ΠΊΠ»ΠΈΠ½ΠΈΡΠ½ΠΈΡΠ΅ ΡΠ°Π΄ΠΈΠΎΠ»ΠΎΠ·ΠΈ ΠΈ ΠΎΠ±ΡΠ°Π·Π½ΠΈ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΡΠΈ. Π‘ΡΡΡΠΎΠΈ ΡΠ΅ ΠΎΡ ΡΠ΅Π΄ΠΈΡΠ° ΡΠ²ΡΡΠ·Π°Π½ΠΈ ΠΏΠΎΠΌΠ΅ΠΆΠ΄Ρ ΡΠΈ ΡΡΠ°ΡΠΈΠΈ Π·Π° Π΄ΠΈΠ°Π³Π½ΠΎΠ·ΠΈ ΠΈ Π΄ΠΈΡΠ΅ΡΠ΅Π½ΡΠΈΠ°Π»Π½ΠΈ Π΄ΠΈΠ°Π³Π½ΠΎΠ·ΠΈ, ΠΏΠΎΠ·Π²ΠΎΠ»ΡΠ²Π°ΡΠΈ Π±ΡΡΠ·ΠΎ ΠΈ ΠΈΠ½ΡΡΠΈΡΠΈΠ²Π½ΠΎ ΡΡΡΡΠ΅Π½Π΅, ΡΠΎΡΡΠΈΡΠ°Π½Π΅ ΠΈ ΡΡΠ°Π²Π½Π΅Π½ΠΈΠ΅ Π½Π° Π½ΠΎΠ·ΠΎΠ»ΠΎΠ³ΠΈΡΠ½ΠΈ Π΅Π΄ΠΈΠ½ΠΈΡΠΈ ΠΈ ΠΎΠ±ΡΠ°Π·Π½ΠΈ Π±Π΅Π»Π΅Π·ΠΈ. Π‘ΠΈΡΡΠ΅ΠΌΠ°ΡΠ° Π΅ ΡΠ½Π°Π±Π΄Π΅Π½Π° Ρ Π±ΠΎΠ³Π°Ρ Π΄ΠΈΠ°ΠΏΠ°Π·ΠΎΠ½ ΠΎΡ ΠΈΠ·ΠΎΠ±ΡΠ°ΠΆΠ΅Π½ΠΈΡ, Π²ΠΊΠ»ΡΡΠΈΡΠ΅Π»Π½ΠΎ ΡΡ
Π΅ΠΌΠΈ ΠΈ ΠΎΠ±ΡΠ°Π·ΠΈ ΠΎΡ ΡΠ°Π·Π»ΠΈΡΠ½ΠΈΡΠ΅ ΠΎΠ±ΡΠ°Π·Π½ΠΈ ΠΌΠΎΠ΄Π°Π»Π½ΠΎΡΡΠΈ, Π²ΡΠΈΡΠΊΠΈ ΠΎΡ ΠΊΠΎΠΈΡΠΎ ΠΏΠΎΠ΄ΡΠΎΠ±Π½ΠΎ Π°Π½ΠΎΡΠΈΡΠ°Π½ΠΈ. Π’Π°Π·ΠΈ ΡΠΈΡΡΠ΅ΠΌΠ° Π±Π΅ Π²ΡΠ²Π΅Π΄Π΅Π½Π° Π·Π° ΠΏΠΎΠ»Π·Π²Π°Π½Π΅ Π² ΠΠ»ΠΈΠ½ΠΈΠΊΠ°ΡΠ° ΠΏΠΎ ΠΎΠ±ΡΠ°Π·Π½Π° Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠ° Π² Π£ΠΠΠΠ βΠ‘Π²Π΅ΡΠ° ΠΠ°ΡΠΈΠ½Π°β β ΠΠ°ΡΠ½Π° Π² Π½Π°ΡΠ°Π»ΠΎΡΠΎ Π½Π° 2017 Π³. ΠΠ°Π΄ Π³ΠΎΠ΄ΠΈΠ½Π° ΡΠ»Π΅Π΄ ΡΠΎΠ²Π° Π±Π΅ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΎ Π²ΡΡΡΠ΅ΡΠ½ΠΎ Π°Π½ΠΎΠ½ΠΈΠΌΠ½ΠΎ ΠΏΡΠΎΡΡΠ²Π°Π½Π΅ Π½Π° ΠΈΠ½Π΄ΠΈΠ²ΠΈΠ΄ΡΠ°Π»Π½ΠΈΡΠ΅ ΠΌΠ½Π΅Π½ΠΈΡ Π½Π° ΠΏΠΎΠ»Π·Π²Π°ΡΠΈΡΠ΅ Ρ Π»Π΅ΠΊΠ°ΡΠΈ β Π² ΡΠΎΠ²Π° ΡΠΈΡΠ»ΠΎ 14 ΡΠΏΠ΅ΡΠΈΠ°Π»ΠΈΡΡΠΈ ΠΏΠΎ ΠΎΠ±ΡΠ°Π·Π½Π° Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠ° ΠΈ 8 ΡΠΏΠ΅ΡΠΈΠ°Π»ΠΈΠ·Π°Π½ΡΠΈ. ΠΠΎΠ±ΠΈΡΠΈΡΠ΅ Π΄Π°Π½Π½ΠΈ Π΄Π΅ΠΌΠΎΠ½ΡΡΡΠΈΡΠ°Ρ ΠΏΡΠ΅ΠΎΠ±Π»Π°Π΄Π°Π²Π°ΡΠΎ ΠΏΠΎΠ·ΠΈΡΠΈΠ²Π½Π° ΠΎΡΠ΅Π½ΠΊΠ° Π½Π° ΠΏΠ»Π°ΡΡΠΎΡΠΌΠ°ΡΠ° StatDx Π² ΠΊΠ»ΠΈΠ½ΠΈΠΊΠ°ΡΠ°.StatDx is an online consultation platform for clinical radiologists and diagnostic imaging specialists. It comprises a large database of interconnected articles on diagnoses and differential diagnoses, allowing for quick and intuitive searches, sorting, and comparison between varying disease entities and between their imaging characteristics. This system is richly illustrated with vast amounts of drawings, schematics and imaging studies, all of which comprehensively annotated. StatDx was introduced to the Department of Diagnostic Imaging at St. Marina University Hospital, Varna in early 2017. Over a year later an anonymous internal study was conducted among the physicians using this system β including 14 specialists in Radiology and 8 Radiology interns. The data acquired pointed at a predominantly positive assessment of StatDx at the Department
Embolization of bronchial arteries in cases of life-threatening bleeding
Massive hemoptysis is a frightening and potentially life-threatening clinical event. Hemoptysis represents a sigΒnificant clinical entity with high morbidity and potential mortality. Bronchial artery angiography with embolization has become a mainstay in the treatment of hemoptysis. Bronchial artery embolization offers a minimally invasive procedure for even the most compromised patient serving as first-line treatment for hemorrhage as well as providing a bridge to more definitive medical or surgical intervention focused upon the etiology of the hemorrhage
Three-year results from the surgical treatment of diseases of the aortic valve and aortic root
PURPOSE: Pathology of the aortic root and aortic valve is subjected to adult cardiac surgery and includes Stanford A aortic dissection, annuloaortic ectasia or chronic aneurysm of the ascending aorta. In such cases, Bentall-De Bono procedure is usually preferred. Aortic valve reimplantation by using Tirone David's technique presenting with the advantages of valve-sparing surgery can be performed in selected cases.MATERIAL AND METHODS: A retrospective analysis of a three-year experience with the complex surgical treatment of diseases of the aortic valve and root was carried out. During the period from January 1, 2009 to December 31, 2012, fifty-three patients with aortic valve and aortic root pathology were treated in the Division of Cardiac Surgery, St. Marina University Hospital of Varna. Bentall procedure was carried out in 37 patients (Group B). In 19 of them (51%) emergency surgery was done for acute aortic dissection of type Stanford A. The rest 18 patients underwent elective surgery for dilated ascending aorta and aortic valve dysfunction. Aortic valve-sparing surgery by David's technique for aortic aneurysm was accomplished in 16 patients (Group D). This technique was emergently applied in one patient with aortic dissection, too. Baseline data, intraoperative details, early results and complications were compared.RESULTS: Early (30-day) mortality after Bentall-De Bono procedure was 10.5% (0% after elective surgery and 21.1% after dissection repair). All the patients survived after David's procedure that proved the significant advantages of the valve-sparing surgery.CONCLUSION: The aortic valve reimplantation provides long-term results that are comparable to those after the Bentall-De Bono procedure such as high survival rates, low incidence rate of endocarditis, and slightly higher risk of reinterventions. There is no need of life-long anticoagulation that improves patient's quality of life.Scripta Scientifica Medica 2013; 45(4): 50-55
Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies
ΠΡΠ²ΠΎΡΠ΅Π½Π°ΡΠ° Ρ
ΠΈΡΡΡΠ³ΠΈΡ Π΅ Π·Π»Π°ΡΠ΅Π½ ΡΡΠ°Π½Π΄Π°ΡΡ Π·Π° Π»Π΅ΡΠ΅Π½ΠΈΠ΅ Π½Π° Ρ
Π΅ΠΏΠ°ΡΠΎΡΠ΅Π»ΡΠ»Π°ΡΠ΅Π½ ΠΊΠ°ΡΡΠΈΠ½ΠΎΠΌ (ΠΠ‘Π‘) ΠΈ ΡΠ΅ΡΠ½ΠΎΠ΄ΡΠΎΠ±Π½ΠΈ ΠΌΠ΅ΡΠ°ΡΡΠ°Π·ΠΈ ΠΎΡ ΡΠ°ΠΊ Π½Π° Π΄Π΅Π±Π΅Π»ΠΎΡΠΎ ΡΠ΅ΡΠ²ΠΎ. ΠΠ½Π΅Ρ ΡΠ΅ΡΠ½ΠΎΠ΄ΡΠΎΠ±Π½Π°ΡΠ° ΡΠ΅Π·Π΅ΠΊΡΠΈΡ Π΅ Π²ΡΠ΅ ΠΎΡΠ΅ ΡΠ°ΠΌΠΎ Π»Π΅ΡΠ΅Π±Π΅Π½ Π²Π°ΡΠΈΠ°Π½Ρ Π·Π° ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΈ Ρ ΡΠ°ΠΊ Π½Π° ΡΠ΅ΡΠ½ΠΈΡ Π΄ΡΠΎΠ±, Ρ 5-Π³ΠΎΠ΄ΠΈΡΠ½Π°ΡΠ° ΠΏΡΠ΅ΠΆΠΈΠ²ΡΠ΅ΠΌΠΎΡΡ ΠΌΠ΅ΠΆΠ΄Ρ 25-60%, Π² ΡΡΠ°Π²Π½Π΅Π½ΠΈΠ΅ Ρ 0% 5-Π³ΠΎΠ΄ΠΈΡΠ½Π° ΠΏΡΠ΅ΠΆΠΈΠ²ΡΠ΅ΠΌΠΎΡΡ Π±Π΅Π· Π½ΠΈΠΊΠ°ΠΊΠ²ΠΈ Π»Π΅ΡΠ΅Π½ΠΈΠ΅. Π‘Π°ΠΌΠΎ 5-15% ΠΎΡ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΈΡΠ΅ Ρ ΠΠ‘Π‘ ΠΈΠ»ΠΈ Ρ ΡΠ΅ΡΠ½ΠΎΠ΄ΡΠΎΠ±Π½ΠΈ ΠΌΠ΅ΡΠ°ΡΡΠ°Π·ΠΈ ΠΌΠΎΠ³Π°Ρ Π΄Π° Π±ΡΠ΄Π°Ρ ΠΏΠΎΠ΄Π»ΠΎΠΆΠ΅Π½ΠΈ Π½Π° ΡΠ΅ΡΠ½ΠΎΠ΄ΡΠΎΠ±Π½Π° ΡΠ΅Π·Π΅ΠΊΡΠΈΡ ΠΏΠΎΡΠ°Π΄ΠΈ ΡΠ°Π·Π»ΠΈΡΠ½ΠΈ ΠΏΡΠΎΡΠΈΠ²ΠΎΠΏΠΎΠΊΠ°Π·Π°Π½ΠΈΡ: Π³ΠΎΠ»ΡΠΌ Π±ΡΠΎΠΉ ΡΡΠΌΠΎΡΠΈ, ΡΡΠΌΠΎΡΠΈ Π½Π° ΡΡΡΠ΄Π½ΠΎΠ΄ΠΎΡΡΡΠΏΠ½ΠΈ ΠΌΠ΅ΡΡΠ°, Π½Π΅Π΄ΠΎΡΡΠ°ΡΡΡΠ΅Π½ ΡΠ΅ΡΠ½ΠΎΠ΄ΡΠΎΠ±Π΅Π½ ΠΎΠ±Π΅ΠΌ Π·Π° ΡΠ΅Π·Π΅ΠΊΡΠΈΡ.Open surgery is a gold standard for treating hepatocellular carcinoma (HCC) and hepatic metastases of colorectal cancer. Today, liver resection is still only a radically option for patients with liver cancer, with a 5-year survival rate of 25-60%, compared with 0% 5-year survival without any treatment. Only 5-15% of patients with HCC or liver metastases may undergo hepatic resection due to different contraindications: a large number of tumors, tumors in hard-to-reach places, insufficient hepatic volume for resection
Minimally invasive ablative techniques of liver tumors
Π‘Π°ΠΌΠΎ 5-15% ΠΎΡ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΈΡΠ΅ Ρ ΠΠ‘Π‘ ΠΈΠ»ΠΈ Ρ ΡΠ΅ΡΠ½ΠΎΠ΄ΡΠΎΠ±Π½ΠΈ ΠΌΠ΅ΡΠ°ΡΡΠ°Π·ΠΈ ΠΌΠΎΠ³Π°Ρ Π΄Π° Π±ΡΠ΄Π°Ρ ΠΏΠΎΠ΄Π»ΠΎΠΆΠ΅Π½ΠΈ Π½Π° ΡΠ΅ΡΠ½ΠΎΠ΄ΡΠΎΠ±Π½Π° ΡΠ΅Π·Π΅ΠΊΡΠΈΡ, ΠΏΠΎΡΠ°Π΄ΠΈ ΡΠ°Π·Π»ΠΈΡΠ½ΠΈ ΠΏΡΠΎΡΠΈΠ²ΠΎΠΏΠΎΠΊΠ°Π·Π°Π½ΠΈΡ: Π³ΠΎΠ»ΡΠΌ Π±ΡΠΎΠΉ ΡΡΠΌΠΎΡΠΈ, ΡΡΠΌΠΎΡΠΈ Π½Π° ΡΡΡΠ΄Π½ΠΎ Π΄ΠΎΡΡΡΠΏΠ½ΠΈ ΠΌΠ΅ΡΡΠ°, Π½Π΅Π΄ΠΎΡΡΠ°ΡΡΡΠ΅Π½ ΡΠ΅ΡΠ½ΠΎΠ΄ΡΠΎΠ±Π΅Π½ ΠΎΠ±Π΅ΠΌ Π·Π° ΡΠ΅Π·Π΅ΠΊΡΠΈΡ. ΠΠ°ΡΠΈΠ°Π½ΡΠΈΡΠ΅ Π·Π° ΠΏΠ΅ΡΠΊΡΡΠ°Π½Π½ΠΎ Π»Π΅ΡΠ΅Π½ΠΈΠ΅ ΠΌΠΎΠ³Π°Ρ Π΄Π° Π±ΡΠ΄Π°Ρ: Π₯ΠΈΠΌΠΈΡΠ½Π°ΡΠ° Π°Π±Π»Π°ΡΠΈΡ: ΠΈΠ½ΠΆΠ΅ΠΊΡΠΈΡΠ°Π½Π΅ Π½Π° Π΅ΡΠ°Π½ΠΎΠ» ΠΈΠ»ΠΈ ΠΎΡΠ΅ΡΠ½Π° ΠΊΠΈΡΠ΅Π»ΠΈΠ½Π°; Π’Π΅ΡΠΌΠ°Π»Π½Π°ΡΠ° Π°Π±Π»Π°ΡΠΈΡ: (Π°) ΠΊΡΠΈΠΎΡ
ΠΈΡΡΡΠ³ΠΈΡΠ½ΠΈ Π°Π±Π»Π°ΡΠΈΡ (CSA/ΠΠ₯Π): ΠΈΠ·ΠΏΠΎΠ»Π·Π²Π°Π½Π΅ Π½Π° ΡΠ΅ΡΠ΅Π½ Π°Π·ΠΎΡ, Π°ΡΠ³ΠΎΠ½, ΠΈΠ»ΠΈ NO2; (Π±) ΠΊΠΎΠ°Π³ΡΠ»Π°ΡΠΈΠΎΠ½Π½Π°ΡΠ°: ΠΈΠ·ΠΏΠΎΠ»Π·Π²Π°Π½Π΅ Π½Π° ΡΠ°Π΄ΠΈΠΎΡΠ΅ΡΡΠΎΡΠ΅Π½ ΡΠΎΠΊ (RFA/Π Π€Π); ΠΠΈΠΊΡΠΎΠ²ΡΠ»Π½ΠΎΠ²Π° Π°Π±Π»Π°ΡΠΈΡ (MWA/ΠΠ); Π»Π°Π·Π΅ΡΠ½Π° ΠΈΠ½ΡΠ΅ΡΡΡΠΈΡΠΈΠ°Π»Π½Π° ΡΠ΅ΡΠΌΠΎΡΠ΅ΡΠ°ΠΏΠΈΡ (ΠΠΠ’Π’) ΠΈΠ»ΠΈ Π²ΠΈΡΠΎΠΊΠΎΠΈΠ½ΡΠ΅Π½Π·ΠΈΠ²Π΅Π½ ΡΠΎΠΊΡΡΠΈΡΠ°Π½ ΡΠ»ΡΡΠ°Π·Π²ΡΠΊ (HIFU/ ΠΠ€Π£); ΠΠ΅ΠΎΠ±ΡΠ°ΡΠΈΠΌΠ° Π΅Π»Π΅ΠΊΡΡΠΎΠΏΠΎΡΠ°ΡΠΈΡ (IRE).Only 5-15% of patients with HCC or liver metastases may undergo hepatic resection due to different contraindications: a large number of tumors, tumors in hard-to-reach places, insufficient hepatic volume for resection. The options for percutaneous treatment can be: Chemical Ablation: Injection of Ethanol or Acetic Acid; Thermal ablation: (a) cryosurgical ablation (CSA): use of liquid nitrogen, argon, or NO2; (b) Coagulation: Radio Frequency Ablation (RFA); Microwave ablation (MWA); Laser Interstitial Thermotherapy (LITT) or High Intensive Focused Ultrasound (HIFU); Irreversible electroporation (IRE)
Neurotoxicity of cancer agents
ΠΠ΅Π²ΡΠΎΡΠΎΠΊΡΠΈΡΠ½ΠΈΡΠ΅ Π΅ΡΠ΅ΠΊΡΠΈ Π½Π° Ρ
ΠΈΠΌΠΈΠΎΡΠ΅ΡΠ°ΠΏΠΈΡΡΠ° ΡΠ΅ ΠΏΠΎΡΠ²ΡΠ²Π°Ρ ΠΎΡΠ½ΠΎΡΠΈΡΠ΅Π»Π½ΠΎ ΡΠ΅ΡΡΠΎ ΠΈ ΡΠ° ΠΏΡΠΈΡΠΈΠ½Π° Π·Π° ΠΌΠΎΠ΄ΠΈΡΠΈΠΊΠ°ΡΠΈΡ Π½Π° Π΄ΠΎΠ·Π°ΡΠ° Π½Π° ΠΌΠ΅Π΄ΠΈΠΊΠ°ΠΌΠ΅Π½ΡΠΈΡΠ΅ - Π΄ΠΎΠ·ΠΎΠ»ΠΈΠΌΠΈΡΠΈΡΠ°ΡΠ° ΡΠΎΠΊΡΠΈΡΠ½ΠΎΡΡ. Π ΠΈΡΠΊΡΡ ΠΎΡ ΡΠ°Π·Π²ΠΈΡΠΈΠ΅ Π½Π° Π½Π΅Π²ΡΠΎΡΠΎΠΊΡΠΈΡΠ½ΠΎΡΡ ΡΠ΅ ΡΠ²Π΅Π»ΠΈΡΠ°Π²Π° Ρ ΠΏΠΎΠ²ΠΈΡΠ°Π²Π°Π½Π΅ Π½Π° ΠΏΡΠΈΠ»ΠΎΠΆΠ΅Π½Π°ΡΠ° Π΄ΠΎΠ·Π° ΠΈ Π·Π° ΡΠ°Π·Π»ΠΈΠΊΠ° ΠΎΡ ΠΌΠΈΠ΅Π»ΠΎΡΠΎΠΊΡΠΈΡΠ½ΠΎΡΡΡΠ° (ΠΎΡΠ½ΠΎΠ²Π½ΠΈΡ ΠΎΠ³ΡΠ°Π½ΠΈΡΠ°Π²Π°Ρ ΡΠ°ΠΊΡΠΎΡ ΠΏΡΠΈ ΠΏΠΎΠ²Π΅ΡΠ΅ΡΠΎ Ρ
ΠΈΠΌΠΈΠΎΡΠ΅ΡΠ°ΠΏΠ΅Π²ΡΠΈΡΠ½ΠΈ ΡΠ΅ΠΆΠΈΠΌΠΈ), ΠΊΠΎΡΡΠΎ ΠΌΠΎΠΆΠ΅ Π΄Π° Π±ΡΠ΄Π΅ ΠΏΡΠ΅ΠΎΠ΄ΠΎΠ»ΡΠ½Π° Ρ ΡΠ°ΡΡΠ΅ΠΆΠ½ΠΈ ΡΠ°ΠΊΡΠΎΡΠΈ ΠΈΠ»ΠΈ ΡΡΠ°Π½ΡΠΏΠ»Π°Π½ΡΠ°ΡΠΈΡ Π½Π° ΠΊΠΎΡΡΠ΅Π½ ΠΌΠΎΠ·ΡΠΊ, Π½ΡΠΌΠ° ΡΡΠ°Π½Π΄Π°ΡΡΠ½ΠΎ ΠΏΠΎΠ²Π΅Π΄Π΅Π½ΠΈΠ΅, ΠΊΠΎΠ΅ΡΠΎ Π΄Π° Ρ ΠΎΠ³ΡΠ°Π½ΠΈΡΠΈ.ΠΡΠΎΡΠΈΠ²ΠΎΡΡΠΌΠΎΡΠ½ΠΈΡΠ΅ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠΈ Π²ΠΎΠ΄ΡΡ Π΄ΠΎ Π΄Π²Π° ΡΠΈΠΏΠ° ΡΠΎΠΊΡΠΈΡΠ½ΠΎΡΡ - ΠΏΠ΅ΡΠΈΡΠ΅ΡΠ½Π° Π½Π΅Π²ΡΠΎΡΠΎΠΊΡΠΈΡΠ½ΠΎΡΡ, ΡΡΡΡΠΎΡΡΠ° ΡΠ΅ ΠΎΡΠ½ΠΎΠ²Π½ΠΎ ΠΎΡ ΠΏΠ΅ΡΠΈΡΠ΅ΡΠ½Π° Π½Π΅Π²ΡΠΎΠΏΠ°ΡΠΈΡ ΠΈ ΡΠ΅Π½ΡΡΠ°Π»Π½Π° Π½Π΅Π²ΡΠΎΡΠΎΠΊΡΠΈΡΠ½ΠΎΡΡ, ΠΊΠΎΡΡΠΎ Π²ΠΊΠ»ΡΡΠ²Π° ΠΎΡ Π½Π΅Π·Π½Π°ΡΠΈΡΠ΅Π»Π½ΠΈ ΠΊΠΎΠ³Π½ΠΈΡΠΈΠ²Π½ΠΈ ΡΠ²ΡΠ΅ΠΆΠ΄Π°Π½ΠΈΡ ΠΈ Π΄Π΅ΡΠΈΡΠΈΡΠΈ Π΄ΠΎ Π΅Π½ΡΠ΅ΡΠ°Π»ΠΎΠΏΠ°ΡΠΈΡ Ρ Π΄Π΅ΠΌΠ΅Π½ΡΠΈΡ ΠΈΠ»ΠΈ Π΄ΠΎΡΠΈ ΠΊΠΎΠΌΠ°.ΠΠ΅ ΡΡΡΠ΅ΡΡΠ²ΡΠ²Π°Ρ ΡΡΠ²ΡΡΠ΄Π΅Π½ΠΈ Π°Π»Π³ΠΎΡΠΈΡΠΌΠΈ Π·Π° ΠΏΠΎΠ²Π΅Π΄Π΅Π½ΠΈΡ ΠΈ ΠΏΡΠΎΡΠΈΠ»Π°ΠΊΡΠΈΠΊΠ° Π½Π° Π½Π΅Π²ΡΠΎΡΠΎΠΊΡΠΈΡΠ½ΠΎΡΡΡΠ°, ΠΏΡΠΈΡΠΈΠ½Π΅Π½Π° ΠΎΡ ΠΏΡΠΎΡΠΈΠ²ΠΎΡΡΠΌΠΎΡΠ½ΠΈΡΠ΅ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠΈ. ΠΠΎΠ²Π΅Π΄Π΅Π½ΠΈΠ΅ΡΠΎ ΠΎΡΠ½ΠΎΠ²Π½ΠΎ ΡΠ΅ ΡΠ²Π΅ΠΆΠ΄Π° Π΄ΠΎ ΡΠ΅Π΄ΡΠΊΡΠΈΡ Π½Π° Π΄ΠΎΠ·Π°ΡΠ° ΠΈΠ»ΠΈ ΠΎΡΠ»Π°Π³Π°Π½Π΅ Π²ΡΠ² Π²ΡΠ΅ΠΌΠ΅ΡΠΎ Π½Π° ΠΏΡΠΈΠ»ΠΎΠΆΠ΅Π½ΠΈΠ΅ΡΠΎ, ΠΎΡΠΎΠ±Π΅Π½ΠΎ ΠΏΡΠΈ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΈ, ΠΊΠΎΠΈΡΠΎ ΡΠ° Ρ ΠΏΠΎ-Π²ΠΈΡΠΎΠΊ ΡΠΈΡΠΊ ΠΎΡ ΡΠ°Π·Π²ΠΈΡΠΈΠ΅ Π½Π° Π½Π΅Π²ΡΠΎΡΠΎΠΊΡΠΈΡΠ½ΠΈ ΡΡΡΠ°Π½ΠΈΡΠ½ΠΈ Π΅ΡΠ΅ΠΊΡΠΈ. ΠΠ° ΡΠΎΠ·ΠΈ Π΅ΡΠ°ΠΏ Π½Π΅ ΡΡΡΠ΅ΡΡΠ²ΡΠ²Π°Ρ Π½Π΅Π²ΡΠΎΠΏΡΠΎΡΠ΅ΠΊΡΠΈΠ²Π½ΠΈ Π°Π³Π΅Π½ΡΠΈ, ΠΊΠΎΠΈΡΠΎ ΡΠ΅ ΠΏΡΠ΅ΠΏΠΎΡΡΡΠ²Π°Ρ Π·Π° ΡΡΠ°Π½Π΄Π°ΡΡΠ½Π° ΡΠΏΠΎΡΡΠ΅Π±Π° ΠΏΡΠΈ ΡΠ°Π·Π²ΠΈΡΠΈΠ΅ Π½Π° Π½Π΅Π²ΡΠΎΡΠΎΠΊΡΠΈΡΠ½ΠΎΡΡ.Neurotoxic side effects of chemotherapy occur frequently and are often a reason to limit the dose of chemotherapy. Chemotherapy dosing is often limited due to a frequently occurring side effect of the treatment - neurotoxic. The risk of neurotoxicity is increased by the possibility of higher dose usage, since bone marrow toxicity (the major limiting factor in most chemotherapeutic regimens) can be overcome with growth factors or bone marrow transplantation.Chemotherapy may cause both peripheral neurotoxicity, consisting mainly of a peripheral neuropathy, and central neurotoxicity, ranging from minor cognitive deficits to encephalopathy with dementia or even coma. Neurotoxicity caused by the chemotherapy can be of two types - peripheral, mainly consisting of peripheral neuropathy and central, from minor cognitive deficits through encephalopathy with dementia to even coma.Data management and neuroprotective agents are still in discussion and there are no current accepted guidelines yet. Management mainly consists of cumulative dose-reduction or lower dose-intensities, especially in patients who are at higher risk to develop neurotoxic side effects. None of the specific neuroprotective agents can be recommended in daily practice for standard use at the moment, and further studies are needed to confirm their beneficial effects
Estudio de viabilidad sobre la transformaciΓ³n de un motor de encendido provocado para su funcionamiento a GLP
Bachvarov, GN. (2011). Estudio de viabilidad sobre la transformaciΓ³n de un motor de encendido provocado para su funcionamiento a GLP. http://hdl.handle.net/10251/15123.Archivo delegad
RecertificaciΓ³n de la ISO/TS 16949 En Prisma Soporte Industrial, S.L
Este proyecto tiene como objetivo la descripciΓ³n del sistema de gestiΓ³n de calidad adoptado por la empresa Prisma Soporte Industrial S.L. El sistema en cuestiΓ³n estΓ‘ basado en la norma ISO 16949 TS, debido a que la empresa realiza su actividad en el sector de automociΓ³n y es imprescindible para que la empresa pueda desarrollar su actividad. En este proyecto se mostrarΓ‘ la historia, el proceso en la empresa, la documentaciΓ³n, el manual de calidad, los procedimientos y los formatos que constituyen el sistema de gestiΓ³n de calidad.Bachvarov, GN. (2016). RecertificaciΓ³n de la ISO/TS 16949 En Prisma Soporte Industrial, S.L. http://hdl.handle.net/10251/84706.Archivo delegad
Tibiopedal access in patients with lower limb peripheral artery disease
Introduction: Peripheral artery disease (also known as PAD) is a common circulatory problem in which narrowed arteries reduce blood flow to the limbs. Atherosclerotic vascular disease affecting the lower extremities is the most common form of peripheral vascular disease. Patients with critical limb ischemia have significant rates of amputation. However, percutaneous options for minimally inΒvasive revascularization exist for most of these patients. In recent years, the retrograde tibiopedal apΒproach is increasingly being used for revascularization of complex chronic total occlusions.Methods and materials: In cases where traditional ipsilateral antegrade or contralateral cross over approaches fail, pedal access approaches utilizing the dorsalis pedis, posterior tibial, or even peroΒneal arteries (most difficult of the three) have been used. The technique is performed by ultrasound guidance using arterial introducers, hydrophilic wires and vasodilators which allow for better access and easier manipulation.Results: In this particular study from a total of 39 cases, a total of 34 cases (87,2%) were successful. Access through ATA was used in 26 of the patients and through PTA in 6 patients. Recanalization of total occlusions was achieved in 14 cases.Conclusion: Preventing amputations can potentially save patient lives and improve quality of life. Tibiopedal access has emerged as an important tool to facilitate successful revascularizations. One of the major advantages of retrograde tibiopedal access is that it allows quick therapy and short proΒcedure time with less observation time in the hospital. The procedure can be used as a viable alternaΒtive to antegrade access interventions. Further well-conducted studies are crucial in generating more high-quality evidence in the field of critical limb ischemia management